Intellia Therapeutics, Inc.
Updated

ntla

124
Описание на графике.
Эта фирма является пионером в разработке редактирования генома CRISPR / Cas9.
Trade closed: target reached
ИКСЫЫЫ

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.